143 related articles for article (PubMed ID: 30655874)
1. Association and clinical implication of the USP10 and MSH2 proteins in non-small cell lung cancer.
Zeng Z; Li D; Yu T; Huang Y; Yan H; Gu L; Yuan J
Oncol Lett; 2019 Jan; 17(1):1128-1138. PubMed ID: 30655874
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-specific Peptidase 10 (USP10) Deubiquitinates and Stabilizes MutS Homolog 2 (MSH2) to Regulate Cellular Sensitivity to DNA Damage.
Zhang M; Hu C; Tong D; Xiang S; Williams K; Bai W; Li GM; Bepler G; Zhang X
J Biol Chem; 2016 May; 291(20):10783-91. PubMed ID: 26975374
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in human non-small-cell lung cancer cells.
Tung CL; Chiu HC; Jian YJ; Jian YT; Chen CY; Syu JJ; Wo TY; Huang YJ; Tseng SC; Lin YW
Exp Cell Res; 2014 Apr; 322(2):345-54. PubMed ID: 24530475
[TBL] [Abstract][Full Text] [Related]
4. Expression and clinical implication of S100A12 in gastric carcinoma.
Li D; Zeng Z; Yu T; Qin J; Wu J; Song JC; Zhou ZY; Yuan JP
Tumour Biol; 2016 May; 37(5):6551-9. PubMed ID: 26638166
[TBL] [Abstract][Full Text] [Related]
5. MSH2/BRCA1 expression as a DNA-repair signature predicting survival in early-stage lung cancer patients from the IFCT-0002 Phase 3 Trial.
Levallet G; Dubois F; Fouret P; Antoine M; Brosseau S; Bergot E; Beau-Faller M; Gounant V; Brambilla E; Debieuvre D; Molinier O; Galateau-Sallé F; Mazieres J; Quoix E; Pujol JL; Moro-Sibilot D; Langlais A; Morin F; Westeel V; Zalcman G
Oncotarget; 2017 Jan; 8(3):4313-4329. PubMed ID: 28008145
[TBL] [Abstract][Full Text] [Related]
6. Dual loss of USP10 and p14ARF protein expression is associated with poor prognosis in patients with small intestinal adenocarcinoma.
Song JS; Yi JM; Cho H; Choi CH; Park Y; Chung EJ; Song J; Chung JY; Hong SM
Tumour Biol; 2018 Oct; 40(10):1010428318808678. PubMed ID: 30375264
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of MSH2 expression by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cells.
Ko JC; Chiu HC; Syu JJ; Chen CY; Jian YT; Huang YJ; Wo TY; Jian YJ; Chang PY; Wang TJ; Lin YW
Biochem Biophys Res Commun; 2015 Jan; 456(1):506-12. PubMed ID: 25490383
[TBL] [Abstract][Full Text] [Related]
8. High MutS homolog 2 expression predicts poor prognosis and is related to immune infiltration in endometrial carcinoma.
Lu X; Ying Y; Zhang W; Li R; Zhang J
Cell Biol Int; 2023 Jan; 47(1):201-215. PubMed ID: 36208091
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of USP10 and p14ARF expression in patients with colorectal cancer.
Kim K; Huh T; Park Y; Koo DH; Kim H; Hwang I; Choi CH; Yi JM; Chung JY
Pathol Res Pract; 2020 Jun; 216(6):152988. PubMed ID: 32362421
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
11. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cells.
Ko JC; Chiu HC; Wo TY; Huang YJ; Tseng SC; Huang YC; Chen HJ; Syu JJ; Chen CY; Jian YT; Jian YJ; Lin YW
Lung Cancer; 2013 Dec; 82(3):397-406. PubMed ID: 24138903
[TBL] [Abstract][Full Text] [Related]
13. Expression of ERCC1, MSH2 and PARP1 in non-small cell lung cancer and prognostic value in patients treated with platinum-based chemotherapy.
Xie KJ; He HE; Sun AJ; Liu XB; Sun LP; Dong XJ
Asian Pac J Cancer Prev; 2014; 15(6):2591-6. PubMed ID: 24761869
[TBL] [Abstract][Full Text] [Related]
14. USP10 inhibits lung cancer cell growth and invasion by upregulating PTEN.
Sun J; Li T; Zhao Y; Huang L; Sun H; Wu H; Jiang X
Mol Cell Biochem; 2018 Apr; 441(1-2):1-7. PubMed ID: 28852924
[TBL] [Abstract][Full Text] [Related]
15. [Expression of TRIM59 in Non-small Cell Lung Cancer and Its Correlation with Prognosis].
Tian H; Zhang D; Xu R; Qin Y; Lan Y; Jiao W; Han Y
Zhongguo Fei Ai Za Zhi; 2020 Jan; 23(1):21-28. PubMed ID: 31948534
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-specific peptidase 10, a deubiquitinating enzyme: Assessing its role in tumor prognosis and immune response.
Ye Z; Chen J; Huang P; Xuan Z; Zheng S
Front Oncol; 2022; 12():990195. PubMed ID: 36248971
[TBL] [Abstract][Full Text] [Related]
17. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].
Yao CC; Lin CY; Hu MB
Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965
[TBL] [Abstract][Full Text] [Related]
18. Expression of flotillin-2 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Wang ZM
Int J Clin Exp Pathol; 2015; 8(1):601-7. PubMed ID: 25755751
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Value and Immune Infiltration of USP10 in Pan-Cancer: A Potential Therapeutic Target.
Gao D; Zhang Z; Xu R; He Z; Li F; Hu Y; Chen H; Lu J; Cao X; Liu Y; Xu Z
Front Oncol; 2022; 12():829705. PubMed ID: 35433424
[TBL] [Abstract][Full Text] [Related]
20. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT/mTOR signaling pathway in non-small cell lung cancer.
Li J; Cheng D; Zhu M; Yu H; Pan Z; Liu L; Geng Q; Pan H; Yan M; Yao M
Theranostics; 2019; 9(1):179-195. PubMed ID: 30662561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
